Crossmark

Docking-based strategy to design novel flavone-based arylamides as potent V600E-BRAF inhibitors with prediction of their drug-likeness and ADMET properties

Crossref DOI link: https://doi.org/10.1186/s42269-020-00432-7

Published Online: 2020-10-16

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Umar, Abdullahi Bello

Uzairu, Adamu

Shallangwa, Gideon Adamu

Uba, Sani
License Information

Text and Data Mining valid from 2020-10-16

Version of Record valid from 2020-10-16
More Information

Article History

Received: 15 September 2020

Accepted: 6 October 2020

First Online: 16 October 2020

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below